2021 Investor Day

Continuing to build on strong channel relationships ResMed TALI Market situation Underpenetrated Australian market Lack of patient awareness for sleep apnea Higher patient responsibility for device costs vs. other markets ResMed solution Focused on new sales channels: distribution, retail stores, pharmacy, and ecommerce Enhanced market presence with "Awaken your best" campaign Created spa-like, consumer- driven retail experience 2021 ResMed | 2021 Investor Day - Sept 8, 2021 Outcome Significantly changed the growth trajectory of the Australian sleep business Increased overall awareness of sleep apnea Improved market growth across all sales channels 75

View entire presentation